vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX), Barinthus Biotherapeutics (NASDAQ:BRNS) and FibroGen (NASDAQ:FGEN).
vTv Therapeutics has a consensus price target of $12.00.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $15.99 last updated December 18, 2024 at 6:39 AM EST.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.